SIGLEC1 and Parkinson disease: To assess the relevance of CD169+ BAMs in human neurodegenerative disorders, we reanalyzed publicly available single-nucleus RNA sequencing (snRNA-seq) data from brain tissue of individuals with Parkinson’s disease (PD) and healthy controls (Prashant et al., 2024).